细菌的代谢途径与抗菌肽耐药性
本文综述代谢基因与抗菌肽(AMP)耐药之间的复杂关系,重点关注代谢途径对耐药各方面的影响。涉及(p)ppGpp、三羧酸循环、血红素生物合成、嘌呤与嘧啶生物合成以及氨基酸与脂质代谢等途径,这些途径以不同方式影响代谢调整、生物膜形成和能量产生,可能参与AMP耐药。作者认为靶向代谢途径及其相关基因可能提高现有抗菌疗效,但仍需进一步研究以阐明具体机制。
要点
- (p)ppGpp、三羧酸循环、血红素合成等代谢途径以不同方式影响代谢调整、生物膜形成与能量产生,可能参与AMP耐药。
- 细菌对AMP存在多种耐药机制,代谢途径在耐药机制中的作用尚未完全明确。
- 作者认为靶向代谢途径及相关基因可能提高现有抗菌疗效,但仍需进一步研究以阐明具体机制。
核心结论
- 细菌对AMP存在多种耐药机制,代谢途径在其中的作用尚未完全明确;作者认为靶向代谢途径及其相关基因可能提高现有抗菌疗效并应对表型与遗传性AMP耐药,但仍需进一步研究以阐明具体机制。
研究设计与样本
- 综述,检索范围及纳入文献数量原文未报告。
主要发现
- 与鸟苷五磷酸(pppGpp)和鸟苷四磷酸(ppGpp)(合称(p)ppGpp)相关的代谢途径、三羧酸(TCA)循环、血红素生物合成、嘌呤与嘧啶生物合成以及氨基酸与脂质代谢,以不同方式影响可能参与AMP耐药的代谢调整、生物膜形成和能量产生。
- AMP因其药效动力学和杀菌机制,与多数传统抗生素相比显示较低的细菌耐药进化风险。
- 细菌对AMP显示不同的耐药机制,代谢途径在耐药机制中的作用尚未完全明确。
临床怎么用
- 作者认为靶向代谢途径及其相关基因可能提高现有抗菌疗效并应对表型(顽固性)与遗传性AMP耐药,原文未据此给出具体临床推荐。
局限性
- 原文指出代谢途径在AMP耐药机制中的作用尚未完全明确,仍需进一步研究以提供对具体机制的深入认识、发现新治疗靶点并助力抗微生物耐药防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial resistance is a pressing concern that poses a significant threat to global public health, necessitating the exploration of alternative strategies to combat drug-resistant microbial infections. Recently, antimicrobial peptides (AMPs) have gained substantial attention as possible replacements for conventional antibiotics. Because of their pharmacodynamics and killing mechanisms, AMPs display a lower risk of bacterial resistance evolution compared with most conventional antibiotics. However, bacteria display different mechanisms to resist AMPs, and the role of metabolic pathways in the resistance mechanism is not fully understood. This review examines the intricate relationship between metabolic genes and AMP resistance, focusing on the impact of metabolic pathways on various aspects of resistance. Metabolic pathways related to guanosine pentaphosphate (pppGpp) and guanosine tetraphosphate (ppGpp) [collectively (p)ppGpp], the tricarboxylic acid (TCA) cycle, haem biosynthesis, purine and pyrimidine biosynthesis, and amino acid and lipid metabolism influence in different ways metabolic adjustments, biofilm formation and energy production that could be involved in AMP resistance. By targeting metabolic pathways and their associated genes, it could be possible to enhance the efficacy of existing antimicrobial therapies and overcome the challenges exhibited by phenotypic (recalcitrance) and genetic resistance toward AMPs. Further research in this area is needed to provide valuable insights into specific mechanisms, uncover novel therapeutic targets, and aid in the fight against antimicrobial resistance.
引用
- Elbediwi M, Rolff J. Metabolic pathways and antimicrobial peptide resistance in bacteria. J Antimicrob Chemother. 2024. PMID: 38742645. doi:10.1093/jac/dkae128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。